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Case presentation
A 63-year-old man was admitted to the Wadsworth Veterans Admin-
istration Hospital for evaluation of azotemia and hypertension. The
patient had been in apparent good health until one year earlier, when
studies during a hospitalization elsewhere revealed a serum creatinine
of 5.2 mgldl, a BUN of 45 mg/dl, and 3+ proteinuria. An intravenous
pyelogram was within normal limits. Hypertension was noted on
admission and antihypertensive medications were given. The patient
subsequently was lost to follow up. Forty years previously the patient
had been hospitalized because of transient gross hematuria of unknown
cause.
On admission to Wadsworth, the patient's blood pressure was 170/100
mm Hg and funduscopic examination revealed artenolar narrowing. The
cardiopulmonary and abdominal examinations were normal, the prostate
was not enlarged, and no edema was present. The rest of the physical
examination was within normal limits. Laboratory findings revealed:
serum creatinine, 10.6 mgldl; BUN, 81 mg/dl; serum sodium, 139
mEq/liter; potassium, 5.3 mEq/liter; chloride, 107 mEg/liter; bicarbonate,
16 mM/liter; calcium, 7.2 mgldl; and phosphorus, 4.5 mgldl. The serum
albumin, bilirubin, glucose, uric acid, and transaminase levels all were
normal. Ultrasound examination revealed small kidneys bilaterally.
The patient was given a diet containing 46 mEq of sodium as part of
his antihypertensive regimen. Within 36 hours he became progressively
somnolent. The blood pressure fell to 90/60 mm Hg in the recumbent
position and 70 mm Hg when the patient was standing.
The patient was transferred to the Metabolic Ward, where 2 liters of
isotonic saline were administered and a dietary sodium intake of 150
mEq/day was instituted. Following stabilization on this diet, the pa-
tient's blood pressure returned to 150/100 mm Hg, and he required
propranolol for optimal blood pressure control.
As part of a protocol to determine the functional adaptation of
surviving nephrons in advanced chronic renal failure, the patient was
subjected to a water immersion study (see Fig. 1). Control plasma
volume, measured by dilution of radiolabeled albumin, was 1908 ml and
the body weight was 71.4 kg. The patient was immersed for 4 hours in
the seated position in a tank of water (kept at a constant temperature of
354 5 C) up to his neck. Both sodium excretion and fractional
excretion of sodium (FENa%) increased during immersion and returned
to nearly baseline levels during the recovery period. Sodium excretion
increased from 113.3 iEq/min in the 60-minute pre study period to 252
iEq/min during the third hour of immersion and returned to 101.3
iEq/min in the recovery (postimmersion) period. The FENa% rose from
9.1% in the prestudy period to 18.8% during the third hour of immersion
and returned to 10.1% in the recovery period. Plasma renin activity
decreased from 1.7 ng/ml/hr in the prestudy period to 0.62 ng/ml/hr by
the fourth hour of immersion. The inulin clearance remained stable
throughout the study at 9 mI/mm. Following this study the sodium
content of the patient's diet was reduced by 20 mEq per day at weekly
intervals.
By the second week of the study, the patient was noted to be losing
more sodium than was provided in the diet. He became hypotensive and
again required intravenous saline to restore a euvolemic state. Dietary
sodium content was returned temporarily to a higher level and subse-
quent decrements in sodium intake were carried out more gradually.
After 3 weeks it was possible to discontinue the antihypertensive
medication and, after 12 weeks, dietary sodium intake had been
reduced to 15 mEq/day. At the end of this period, the patient's weight
was 68 kg and his plasma volume was 2174 ml. He was excreting 13 to
20 mEq of sodium daily.
A second water immersion study revealed that sodium excretion and
FENa% again increased during the period of immersion, but both
control and immersion values were considerably lower than those
observed during the initial study. Sodium excretion increased from 4
Eq/min in the prestudy period to 55 p.Eq/min by the third hour and
returned to 29.6 i.Eq/min in the recovery period. Similarly, the FENa%
increased from 1.49% to 6.9% by the third hour and returned to 3.1% in
the recovery period. The plasma renin activity decreased from 3.2
nglml/hr to 1.9 ng/ml/hr during the fourth hour of immersion. Measure-
ment of natriuretic factor by rat bioassay, which had been negative
during the first water immersion study, turned positive during the
second. The inulin clearance was lower than before (6 mI/mm) but
remained stable during the study.
Following completion of this study, the patient was given a diet
containing 80 mEq/day of sodium and was observed for 7 days, after
which vascular access was created for subsequent dialysis. On dis-
charge the patient had a serum creatinine of 10.8 mg/dl and a blood
pressure of 130/85 mm Hg.
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Discussion
DR. NEAL S. BRICKER (Professor of Medicine, Director,
Program in Kidney Diseases, UCLA School of Medicine, Los
Angeles, California): If one could eliminate nephrons one at a
time in 2 million consecutive steps while maintaining salt intake
constant, the continued preservation of sodium balance would
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Fig. 1. Effect of water immersion on fractional excretion of sodium
during two levels of dietary sodium intake. Upper curve represents
results of water immersion to neck in "adapted" uremic patient. Lower
curve represents results of water immersion in same patient following
"de-adaptation." Details of de-adaptation are included in text.
require resetting the rate of sodium excretion by all surviving
nephrons 2 million times. Thus, each time another nephron is
destroyed, the average rate of sodium excretion by each
surviving nephron would have to increase to avoid permanent
sodium retention, even though the mean increment might be as
small as 5 x 1O mEq/min/nephron.
Although single-file destruction of nephrons does not occur in
chronic renal disease, it is the rule rather than the exception
that sodium balance is maintained until the vast majority of the
original nephron population has been destroyed. How a system
might operate to preserve sodium homeostasis in the presence
of the relentless destruction of nephrons and a constant salt
intake, effecting precise changes in the average rate of sodium
excretion per nephron as small as those quoted above, consti-
tutes a major area of current interest and inquiry.
Special problems created by chronic renal disease
Variation in excretory rates among nephrons. Figure 2 de-
picts values for single-nephron sodium excretion rates in 3
hypothetical subjects ingesting the same amount of salt daily:
(1) a normal person; (2) a patient with chronic renal disease
secondary to chronic glomerulonephritis; and (3) a patient with
chronic interstitial nephritis. The three bars for each subject
refer to different subsets of nephrons, based on mean values for
single-nephron GFR (SNGFR). The data, as will be discussed,
provide a compelling case for the existence of a complex
biologic control system for the regulation of sodium homeosta-
sis. I will attempt to describe the biologic task confronting such
a control system and to emphasize some of the obstacles that
must be overcome if the task is to be accomplished. Finally, I
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Fig. 2. Sodium excretion per nephron (nEqimin) when the intake is 120
mEqlday. Each bar represents one-third of the total nephron population
for each of three hypothetical subjects based on mean values for single-
nephron GFR. The values for single-nephron GFR for each of the
subgroups are shown in Table 2. The basis for the calculations used to
derive the values for sodium excretion rate per nephron is described in
the text.
will present a model for a control system that can operate in
chronic renal disease as well as in health.
The data in Figure 2 are based on the following assumptions:
All 3 subjects are the same size (70 kg), have the same
extracellular fluid volume (14 liters), and have the same serum
sodium concentration (140 mEq/liter). All 3 ingest the same
amount of sodium daily (120 mEq/day), and all 3 excrete the
same amount of sodium daily (120 mEq); hence all 3 maintain
external sodium balance with equal precision.
Table 1 presents an estimate of the number of nephrons in
each subject and of the mean value for SNGFR of these
nephrons. The normal person has a GFR of 120 mI/mm and 2
million nephrons. Both patients have GFRs of 2 mI/mm. How-
ever, patient A, who has chronic glomerulonephritis, has
100,000 nephrons, whereas patient B, who has interstitial
nephritis, has approximately 33,000 nephrons. The reason for
the threefold difference in the number of nephrons in 2 patients
with equal whole-kidney GFRs is that the average value for
single-nephron GFR is three times as great in patient B as in
patient A.
In each subject, as already noted, the nephrons have been
divided into three subgroups, each having a different mean
value for SNGFR. These data are shown in Table 2. To simplify
the calculations, each subgroup is assumed to have one-third of
the total number of functioning nephrons. I should point out
here that the values assigned for SNGFR represent extrapola-
tions from studies in experimental animals with normal kidneys,
kidneys with severe glomerular lesions, and kidneys with
interstitial lesions [1—121.
Figure 2 clearly shows that the values for sodium excretion
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Table 1. Details of adaptation in sodium excretion: Total number of
nephrons and mean SNGFR valuea
Subject Diagnosis
GFR
(mi/mm)
Number of
nephrons
Mean
SNGFR
(nI/mm)
1 Normal 120 2 million 60
2 Patient A
(chronic GN)
2 100,000 20
3 Patient B
(interstitial
nephritis)
2 33,400 60
a SNGFR refers to single-nephron glomerular filtration rate.
Table 2. Details of adaptation in sodium excretion: Nephron
subgroups
Subject Diagnosis
Nephron
subgroups
Mean value
SNGFR/nephron
(nl/min)
1 Normal
A
B
C
50
60
70
2
Patient A
(chronic ON)
A
B
C
10
20
30
3
Patient B
(interstitial
nephritis)
A
B
C
30
60
90
rates per nephron in the normal subject differ to an astonishing
degree from the values in both patients. Remarkable differences
also are evident between patient A and patient B. Finally, in the
normal subject, the values for each subgroup are somewhat
different from one another, and in the 2 patients the variation
among subgroups is striking. Yet in all 3 subjects, the single-
nephron sodium excretion rates occur in response to the
ingestion of the same amount of salt, and, at the end of each 24-
hour period, each subject excretes the same total amount of
sodium into the urine.
Variation in proximal tubular sodium reabsorptive rates. The
potential problems confronting a biologic control system
charged with maintaining sodium homeostasis become even
more complex when, the calculated values for net sodium
reabsorption in different nephron segments of the individual
subgroups of each of the subjects are examined. Values for
proximal reabsorption are shown in Table 3. We can assume
that homogeneity of glomerulotubular (G-T) balance is main-
tained in all 3 subjects [13J and that by the end of the accessible
portion of the proximal tubule, all nephrons, irrespective of
their subgroup, have reabsorbed 50% of the filtered sodium.
Despite the equal values for fractional reabsorption, however,
there are 7 different values for absolute sodium reabsorption for
the 9 nephron subgroups. These values range from 0.7 to 6.3
nEq/min/nephron. Underscoring the seemingly random quality
of the mechanism we are attempting to analyze, the subgroup of
nephrons with the highest rate of sodium excretion per nephron
Table 3. Details of adaptation in sodium excretion: Proximal tubular
sodium reabsorptiona
Subject
Nephron
subgroup
SNGFR
(ni/mm)
Proximal Sodium
reabsorption excretion
(nEqlmin/nephron)
Normal
A
B
C
50
60
70
3.5
4.2
4.9
.035
.042
.049
Patient A
(chronic ON)
A
B
C
10
20
30
0.7
1.4
2.1
0.43
0.86
1.29
Patient B
(interstitial
nephritis)
A
B
C
30
60
90
2.1
4.2
6.3
1.25
2.49
3.74
a 50% of the filtered sodium is assumed to be reabsorbed proximally
in all groups.
(patient B, subgroup C) simultaneously has the greatest rate of
proximal reabsorption of any of the 9 groups.
Variation in distal sodium reabsorptive rates. Values for
single-nephron sodium reabsorption for the segment of the
nephron beyond the accessible portion of the pars convoluta of
the proximal tubule are shown in Figure 3. The subjects and
subgroups are the same as those in Figure 2. For each sub-
group, the per-nephron rate of distal reabsorption is compared
with the calculated value for sodium excretion. In all 3 subjects,
tubulotubular (T-T) balance, as well as G-T balance, is assumed
to remain homogeneous throughout the entire nephron popula-
tion. Based on the calculated rates of distal sodium delivery
(50% of the filtered load) and sodium excretion, 90% of the
distal sodium load is reabsorbed by the nephrons of the normal
subject, 38% by the nephrons of patient A (with chronic
glomerulonephritis), and 40% by the nephrons of patient B
(with interstitial nephritis). If lower values for fractional reab-
sorption in the proximal tubule are used in one or both patients,
the values for absolute distal reabsorption will increase, but the
dispersion of values among the different subgroups will be
qualitatively the same.
In the normal subject, the degree of variation in reabsorption
rates among the three subgroups is moderate. Within the 6
subgroups of the 2 patients, however, distal reabsorption rates
vary over a range of almost tenfold. Moreover: (1) the mean
value is different in each of the 6 subgroups; (2) the overall
mean value (i.e., for the 3 subgroups combined) in patient B is 3
times the comparable value in patient A; and (3) in all 6
subgroups, the values for distal reabsorption are less than the
lowest value in any of the subgroups in the normal subject. I will
come back to the last observation later when considering the
possible role of aldosterone in the control of sodium excretion
in chronic renal disease.
The effect of a change in sodium intake. The physiologic
response to a change in salt intake adds further to our difficulty
in interpreting the characteristics of the control system. Table 4
depicts the effects of a modest increase in sodium intake (from
60 to 120 mEq/day) on single-nephron sodium excretion rates.
To simplify the presentation, data are shown for only 2 nephron
subgroups, group A in the normal subject and group C in patient
B. In response to an identical change in salt intake, equal to
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Fig. 3. Distal sodium reabsorption compared with sodium excretion per
nephron (nEqimin). Six bars are shown for each of the 3 subjects. For
each set of two bars, the one on the right represents sodium excretion
per minute per nephron and the values are the same as those shown in
Figure 2. The left-hand bars represent the calculated values for net
sodium reabsorption beyond the last point of the "proximal tubule"
accessible to micropuncture. The assumption is made that 50% of the
filtered sodium was reabsorbed proximally in each of the three subsets
of all 3 subjects. The effects of using different values for fractional
reabsorption in the 2 uremic patients are commented on in the text.
3.5 g of sodium chloride per day, the increase in sodium
excretion per nephron is 100 times greater in the patient's
nephron than in that of the normal person. It might be noted
that if all 2 million nephrons in the normal subject responded as
did the group C nephrons in patient B, the 24-hour sodium
excretion would greatly exceed the total amount of sodium in
the extracellular fluid. Obviously, life would terminate long
before the 24 hours passed. On the other hand, life persists in
the patient because of the magnified natriuretic response.
Let me reemphasize that: (1) A wide range of values exists for
proximal sodium reabsorption; (2) there is a wide range of
values for distal sodium reabsorption; and (3) an especially wide
range of values is found for overall sodium excretion per
nephron. These differences obtain when one compares one
patient with the other, and they obtain when one compares an
individual nephron subgroup with another. Yet all 3 subjects
excrete identical amounts of sodium in their urine daily. The
system that subserves the maintenance of sodium balance
would seem to possess remarkable, if not mysterious, qualities.
Adaptation
For sodium homeostasis to be maintained in advancing
chronic renal disease, the addition of any given amount of
sodium to the extracellular fluid must progressively raise the
Sodium
excretion
(nEqim in!
nephron)
Total
Subject
GFR
(mI/mm) Nephrons
SNGFR
(ni/mm)
60 mEq 120 mEq
dieta dieta
Normal' 120 2,000,000 50 .018 .035 .018
Patient BC 2 33,400 90 1.87 3.74 1.87
(interstitial
nephritis)
average rate of sodium excretion per nephron as GFR falls. We
have termed this central feature of the adaptation in sodium
excretion in chronic renal disease the "magnification phenome-
non" [14].
Of the many examples of the magnification phenomenon,
perhaps the most graphic is the continued ability of patients
with chronic renal disease to maintain external sodium balance
on an unrestricted salt intake as GFR falls from normal to
extremely low levels [15]. To accomplish this on a relatively
constant sodium intake, FENa% must double with each 50% fall
in GFR [16]. In Figure 4, values for whole-kidney FENa% are
shown for the same 3 subjects described earlier (the FENa%
values represent 24-hour averages). On the identical sodium
intake of 120 mEq/day, the normal person excretes 0.5%of the
filtered sodium (i.e., 1 of 200 filtered sodium ions), whereas in
each of the 2 patients, FENa% equals 32%. Presumably, these
values for FENa% are the same for all the nephrons in the
individual subjects regardless of SNGFR values.
Another example of the magnification phenomenon is seen
when extracellular fluid is translocated from one portion of the
body to another without changing total extracellular fluid
volume. If a human is immersed in a tank of water to the level of
the neck, there is a shift of extracellular fluid from the legs into
the upper portions of the body, In normal individuals, the
increase in central and intrathoracic extracellular fluid volume
is attended by a natriuresis [17]. When patients with chronic
renal disease of varying severity are subjected to water immer-
sion, not only does sodium excretion increase, but the lower the
steady-state GFR, the greater is the rise in FENa% (Epstein M,
Hoffman D, DeNunvio AG, unpublished observations). These
patients are nonedematous, in external sodium balance, and
presumably the volume of fluid translocated is closely compara-
ble irrespective of the level of the GFR.
The phenomenon of "de-adaptation"
The typical patient with chronic renal disease exhibits a salt-
losing state when GFR falls below 30 ml/min. In most instances,
this condition is characterized by the patient's inability to
reduce the obligatory sodium excretion in the urine to less than
Normal
GFR 120 mI/mm
2,000,000 nephrons
Chronic G N
GFR 2 mI/mm
100,000 nephrons
ISN
GFR 2 mI/mm
33,400 nephrons
Table 4. Details of adaptation in sodium excretion:
increasing sodium intake from 60 to 120 mEq/day on
sodium excretion
The effects of
single-nephron
The values for sodium intake are for 24-hour periods.b The data for the normal person are from Subgroup A (Table 2 and
Figure 2).
The data for Patient B are from Subgroup C (Table 2 and Figure 2).
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GFR 120 mI/mm GFR 2 mI/mm GFR 2 mI/mm
2,000,000 nephrons 100,000 nephrons 33,400 nephrons
Fig. 4. Fractional excretion of sodium when the intake is 120 mEqiday.
The value for fractional reabsorption of sodium in each subject repre-
sents the composite mean for all functioning nephrons (i.e., the values
for the three subsets have been averaged). As discussed in the text, the
preservation of homogeneity of G-T and T-T balances would make the
values for fractional (but not absolute) excretion the same in all three
nephron subsets of each subject. The calculated values are for a 24-hour
period and assume that the total amount of sodium excreted is equal to
the total amount ingested (i.e., 120 mEq/day).
approximately 30 mEq/24 hours despite restriction of the di-
etary sodium intake to less than this level [18]. Rarely, the
obligatory sodium loss can be much higher, exceeding 200 to
300 mEq/day [19, 20]. If the sodium intake is diminished below
the "floor" of sodium excretion, negative sodium balance will
ensue, and a contraction of extracellular fluid volume necessari-
ly will follow,
The general explanation for the salt-losing state of chronic
renal disease has varied from the dictates of electrical neutrality
imposed by the excretion of unreabsorbable anions to a tubular
defect in sodium reabsorption. It also has been thought that
there is a limitation in the lower limit of sodium concentration
achievable in the urine and thus that the magnitude of sodium
loss varies with urine flow [18]. An entirely different explana-
tion for the salt-losing has emerged from recent studies by
Danovitch, Bourgoignie, and Bricker [20]. Patients with chronic
renal disease whose GFRs ranged from 5.2 to 16 mI/mm were
maintained in a metabolic balance ward from 4 to 14 weeks. The
initial sodium intake, based on a detailed dietary history, varied
from 58 to 342 mEq/day. In each subject, salt intake was
reduced by small amounts at intervals of no less than one week.
At the end of the study period, all the patients could maintain
sodium balance on a diet containing 5.0 2.9 (SD) mEq/day.
Moreover, there was no reduction in GFR or in estimated
plasma volume, nor were any adverse effects noted. The salt-
losing state in these patients thus was reversed by slow and
gradual "weaning" of sodium intake. The explanation proposed
was that the adaptation in sodium excretion in chronic renal
disease that results in the high rates of sodium excretion per
nephron at low GFRs is not rapidly suppressible, but that "de-
adaptation" can be induced if sodium withdrawal is accom-
plished slowly over a long period. The patient under discussion
today is a good example of this de-adaptive response.
Certain of the effects of de-adaptation on the magnification
phenomenon recently have been studied by Rever, Licht, and
Bricker (unpublished observations). Using the same salt-wean-
ing technique just described, we subjected patients with chronic
renal disease to water immersion before and after the sodium-
losing state was reversed. The resulting data clearly demon-
strate that the magnified natriuretic response to water immer-
sion in adapted patients with chronic renal disease is blunted
following the de-adaptation process (Fig. 1). Measurements of
plasma volume before and after de-adaptation showed no
change. Our present interpretation is that the magnification
phenomenon for sodium depends on the preexistence of an
adaptive natriuresis per nephron, but further documentation of
this thesis is necessary.
General design of the sodium control system
I already have emphasized the view that a sophisticated
biologic control system seems to be required for the mainte-
nance of sodium balance. I also believe that although qualitative
changes in the mode of operation of this system occur continu-
ously as GFR falls, the basic components of the system must be
the same in a patient with advancing chronic renal disease as in
a normal person. If these views are correct, it follows that each
person not only is born with a sodium control system, but that
the system is designed so as to alter its patterns of function
progressively in any individual who becomes afflicted with a
nephron-destroying process.
The control system is believed to contain a minimum of three
component parts [15]. The first is a detector element capable of
sensing an alteration in body fluids produced by the addition or
loss of sodium chloride. The second is a transmittingelement
capable of relaying information about the perturbation of the
extracellular fluid to the nephrons and altering their rate of
sodium transport. The third is the endorgan, which consists of
the total pool of functioning nephrons whether the number be 2
million or 30,000. There also is a possibility that an integrator
element may exist if there is not a single detector element, but
rather widely dispersed detector elements. The integrator,
presumably located in the central nervous system, would
receive the input from all detector elements, collate the data,
and determine whether the message sent to the kidneys via the
transmitter is to increase or to decrease the rate of sodium
excretion. An integrator would be of special value in the
presence of internal translocations of volume such as water
immersion wherein there is a decrease in the effective extracel-
lular fluid volume in the legs and a simultaneous increase in the
thorax.
The detector element. Neither the location nor the nature of
the detector element is yet known. It seems most likely,
however, that the perturbation that is monitored is a change in
extracellular fluid volume or a hemodynamic alteration induced
by a volume change, rather than a change in the extracellular
fluid sodium concentration per Se. Thus, the sodium control
system in fact is probably a volume control system, and sodium
balance is maintained by virtue of the usually close coupling
between changes in extracellular fluid sodium content and
extracellular fluid volume.
Several lines of evidence suggest that the detector element is
located in the upper half of the body, possibly within the thorax,
perhaps in the brain. In addition to the water immersion studies,
space flight is associated with an early natriuretic response; the
change from the l-g environment of earth to the 0-g environ-
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ment of space is attended by the movement of approximately 2
liters of fluid from the lower extremities into the more cephalad
portions of the body [211. Prolonged bedrest also leads to a
cephalad shift of extracellular fluid and typically produces a
natriuresis. Movement of extracellular fluid volume from the
upper to the lower portions of the body, such as is induced by
quiet standing and application of thigh tourniquets, also
changes sodium excretion, but in the opposite direction [221.
The integrator element. The basis for considering the exis-
tence of a centrally located "computer"-type mechanism that
would monitor simultaneous, and in some instances opposing,
changes in regional extracellular fluid volumes already has been
alluded to. If such an integrator element exists, however, its
location and mechanism of action remain unknown.
The transmitting element. There is an extensive and growing
list of factors known to influence sodium excretion. Among
these are: (1) changes in GFR throughout the nephron popula-
tion; (2) changes and/or redistribution of GFR values in cortical
versus juxtamedullary glomeruli; (3) changes in medullary
blood flow with an alteration of sodium concentration gradients
between the medullary interstitium and the vasa recta and loop
of Henle; (4) changes in sympathetic nervous activity; and (5)
alterations in the activity of one or more of a number of humoral
substances including aldosterone, prostaglandins, vasopressin,
oxytocin, the kallikrein-kinin system, parathyroid hormone,
calcitonin, and finally the putative natriuretic hormone.
For any one of the foregoing factors to be established as the
key modulator of sodium excretion, its activity must be shown
to correlate closely and consistently with both short- and long-
term changes in sodium excretion under many different circum-
stances, including chronic renal disease. None of the factors
listed has yet been examined under enough circumstances to
establish which, if any, is the principal modulator of sodium
excretion. It does appear, however, that most of the factors
listed can be excluded on the basis of negative correlations. The
evidence in regard to aldosterone and natriuretic hormone will
be considered later.
The end organ: The nephron. A vast amount of data relating
to the manner in which sodium is handled by the nephron has
been accumulated, and most of this information falls beyond the
scope of this discussion. But I would like to comment a little
later about the possibility that intrinsic changes in nephron
function might contribute to the magnification phenomenon.
Special comments about aldosterone and natriuretic hormone
Aldosterone. Clear and incontrovertible evidence shows that
aldosterone augments epithelial cell sodium transport capacity.
However, the biologic role of aldosterone in regulating tubular
reabsorption of sodium seems to involve the induction of the
synthesis of proteins concerned with sodium transport rather
than the modulation of the minute-to-minute rate of sodium
transport and excretion [23]. In chronic renal disease, the
pattern of change in aldosterone levels is not consistent as GFR
falls from normal to low levels. Elevated levels have been
reported, yet in the data shown in Figure 3, values for distal
tubular reabsorption in the 2 patients were lower in all nephron
subgroups than in any of the 3 subgroups in the normal subject.
The values were particularly low in the patient with glomerulo-
nephritis. A number of experimental observations also fail to
support the view that aldosterone is the primary "transmitter"
in the sodium control system in chronic renal disease [16, 24,
25].
Natriuretic hormone. Although natriuretic hormone has not
yet been isolated and synthesized, the body of evidence sup-
porting its existence is compelling. Much of this evidence has
been reviewed in a recent monograph [26]. I will limit my
comments about natriuretic hormone to a brief summary of
certain of the more relevant data. The natriuretic factor, the
term I generally prefer to use rather than natriuretic hormone, is
a low-molecular-weight compound (approximately 500 daltons),
which has been separated from the serum and urine of uremic
patients who have high fractional sodium excretion rates [27,
28]. Because natriuretic factor is present in increased amounts
in both the serum and urine of uremic patients, one can assume
that its rate of production is increased in uremia. Natriuretic
factor is not detectable, however, in the urine or serum of
patients with advanced chronic renal disease who are nephrotic
and edematous and, hence, are not undergoing a natriuresis
[28]. A sodium transport inhibitor, probably the same substance
present in uremia, also has been found in: (I) normal individuals
ingesting a high-salt diet [29]; (2) healthy dogs ingesting 15 g of
sodium chloride and 0.2 mg of fludrocortisol per day following
escape [30]; (3) normal subjects during water immersion [31];
(4) patients with aldosterone-secreting tumors (sodium trans-
port inhibition disappears following removal of the tumor) [32];
and (5) patients with head trauma who are manifesting a
natriuresis [33].
As in nephrotic uremic patients, natriuretic activity was not
demonstrable with standard bioassay techniques in uremic dogs
in which the typical natriuresis per nephron was prevented by a
reduction in dietary sodium intake in exact proportion to the
reduction in GFR [34]. Activity also was absent in patients with
head trauma in whom a natriuretic state did not develop [33].
We have studied 2 patients with chronic renal disease in whom
assays for natriuretic activity in the urine were inexplicably
negative; but in both the assays became positive during water
immersion (Rever B, Licht A, Bricker NS, unpublished
observations).
Natriuretic factor inhibits sodium transport by the isolated
toad bladder [28], the isolated frog skin [28], the isolated
perfused cortical collecting tubule of the rabbit [35], and two
cell types grown in tissue culture (Licht A, Bricker NS,
unpublished observations). One of these cell lines, the so-called
"MDCK" strain, originally was derived from tubular epithelial
cells of the dog. The other, the 3T6 strain, is a line of fibroblasts
that actively transports sodium. Finally, natriuretic factor pro-
duces a sodium diuresis both in the normal water-loaded rat [36]
and in the uremic rat fed a high-salt diet for 36 to 48 hours
before the material is administered [28].
In the isolated tubule preparation, toad bladder, and the frog
skin, natriuretic factor is active only when added from the
basolateral, or the "blood," surface [37]. It increases the
intracellular sodium content of isolated toad bladder epithelial
cells and decreases their rate of pyruvate oxidation [38].
Natriuretic factor inhibits sodium efflux in the isolated perfused
tubule but does not affect sodium influx [35]. It inhibits sodium
efflux by both the MDCK and the 3T6 cell systems and does not
produce further inhibition of sodium efflux in the same cell
types incubated in l0 M ouabain (Licht A, Bricker NS,
unpublished observations). It inhibits rubidium influx in the 3T6
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system (Licht A, Bricker NS, unpublished observations), but it
is not kaliuretic in the rat [27, 281.
Intensive efforts are in progress to isolate natriuretic factor,
and a relatively high degree of purity has been obtained using
high-performance liquid chromatography. The active fraction is
water soluble, soluble in some organic solvents [36, 39] but not
in others, and presumably is polar in nature. Natriuretic factor
appears in a chromatographic peak (using high-performance
liquid chromatography) that contains an active amine group; it
is inactivated by some proteolytic enzymes but not by others,
and disagreement still exists as to whether it is a peptide. Many
of its effects resemble those of ouabain, and it has been
suggested that natriuretic factor might be an endogenous digital-
is glycoside-like compound [40].
Operation of the control system: A hypothetical model
The model to be presented fits within the classic framework
of a "detector-transmitter-end organ" system that maintains
sodium homeostasis by controlling the constancy of effective
extracellular fluid volume. Given the changing circumstances
inherent in advancing renal insufficiency, how does such a
system continue to operate? In essence, how can a specific
amount of sodium, an amount that can vary from meal to meal
and day to day, be excreted with some precision by a popula-
tion of nephrons that varies in number from 2 million to perhaps
30,000 and that can exhibit the spectrum of values for proximal
and distal sodium reabsorption and sodium excretion per neph-
ron, exemplified by Figures 2 and 3 and Table 3? We can focus
this question around two related issues: (1) is there a mecha-
nism that serves as the "control center," overseeing the
continuous operation of the system and overriding seemingly
insurmountable obstacles; and (2) how can the magnification
phenomenon be explained?
The "control center." Theoretically, the system could be
"effector oriented," that is, have its control center located in
the kidneys per se, or it could be "detector oriented," and have
the control center located anywhere in the body. The first
possibility would require that the kidneys possess a means of
determining how much sodium is acquired daily and thus how
much must be excreted. Following the addition of sodium to the
extracellular fluid, excretion per nephron then would have to be
increased, presumably by a reduction in distal sodium reabsorp-
tion [35]. The reabsorption of sodium might emit some bio-
chemical signal and a feedback loop then might modulate the
rate of release of a transmitter element and evoke a subsequent
decrease (or increase) in distal sodium reabsorption. However,
a model that places the control center in the kidneys leaves a
major problem unsolved. For the end organ to monitor the rate
of addition (or deletion) of sodium to the extracellular fluid, a
sensing device would be required. Despite the intrarenal loca-
tion of such a hypothetical sensor, it nevertheless would be
monitoring a volume-related, presumably hemodynamic,
change. In this sense, such a control system would be just as
"detector oriented" as it would be if it resided in the chest
rather than in the renal parenchyma. Thus, we believe the
volume control system can be viewed as detector oriented with
its "control center" probably residing in the detector element
per se. Let us examine a working model of the system having
the general design presented in Figure 5.
The model control system is designed to maintain an optimal
Basal state
ECF_))uTse
Detector
NaCI ingestion
Postprandial
overshoot /
extracellular fluid volume. The upper portion of the figure
depicts the basal state, wherein the volume of the extracellular
fluid is normal. The detector element receives little input and
sends out only minimal pulses to the site of synthesis of the
major transmitter element, which we will assume for the
present discussion is natriuretic hormone. In health, in the basal
state, the level of the hormone in the circulation is low, the
degree of inhibition of distal tubular sodium reabsorption is
small, and urinary sodium excretion is minimal. This basal state
would prevail some hours after the ingestion of a meal and
perhaps would be most characteristic of the pattern observed
during early morning.
The middle panel in Figure 5 depicts the effects on the control
system of the ingestion of sodium chloride. The entrance of the
NaC1 into the extracellular fluid leads to isosmotic expansion of
the extracellular fluid as previously noted. The detector ele-
ment then senses the expansion through a still-to-be-defined
hemodynamic event induced by the expansion, and the activity
of the detector is markedly increased over that which prevailed
in the basal state. The result is that the pulses sent out to the
organ producing the transmitter are increased; the thick black
arrow in the figure depicts a marked increase in the rate of
release of the transmitter substance. The transmitter, which
again is assumed to act by inhibiting distal tubular sodium
transport, will, after reaching the nephrons via the renal circula-
tion, diminish net sodium reabsorption per nephron and thereby
increase sodium excretion per nephron. The concentration of
the inhibitor in the postglomerular blood should be identical for
all nephrons (with the possible exception of the juxtamedullary
units) and, if the number of receptor sites for the transmitter is
-
Fig. 5. Proposed model of the biologic control system for sodium. N. H.
stands for putative natriuretic hormone.
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proportional to SNGFR, and the affinity of the unoccupied sites
is constant from nephron to nephron, the number of new
transmitter molecules that will attach to the unoccupied recep-
tors also should be proportional to SNGFR. Hence, the per-
centage change in distal tubular sodium reabsorption of the
distal load of sodium would be identical in all nephrons and
would be determined by (1) the concentration (or activity) of the
transmitter element in the blood; (2) the affinity of the receptor
sites for the inhibitor; and (3) the number of new receptor sites
occupied. Despite the homogeneous change in the percentage
of distal sodium reabsorption, as discussed previously, the
actual number of sodium ions prevented from crossing the
epithelial cells, and thus remaining in the tubular fluid to be
excreted, will vary from one nephron to another in the same
kidney depending on the distal load of sodium, and the latter
will depend, in turn, on the value for SNGFR. The dispersion of
values for sodium excretion rate per nephron, as shown in
Figure 2, thus will vary widely as does SNGFR. Nevertheless,
the effect of the increased activity of the transmitter on the
residual nephrons, regardless of their number, will be to in-
crease total sodium excretion.
The bottom panel represents the system's status after the
transmitter has exercised its effects on the nephrons. All the
ingested sodium chloride has been excreted, but the possibility
exists that an "overshoot" phenomenon might be involved. It
seems likely that as the extracellular fluid volume is restored
toward normal, the stimulus to the detector element will
diminish pan passu. It also seems likely, however, that the
system cannot operate with absolute precision and that the
extracellular fluid volume will fluctuate about an "ideal" vol-
ume. Thus, despite the fact that the full amount of added
sodium chloride has been excreted, the activity of the transmit-
ter may persist at a level greater than basal for a finite period
and result in a continuing, albeit diminished, natriuresis. The
overshoot phase should be self-limited, and when additional
sodium chloride is ingested, the extracellular fluid volume will
first return to the basal level and then undergo expansion.
In essence, therefore, with a detector-oriented model, the
natriuresis attendant on the addition of sodium chloride to the
extracellular fluid will begin to abate as the extracellular fluid
volume begins to diminish toward normal. Activation of the
detector in this model plays a key role in determining the rate of
release of the transmitter element. The model provides for the
preservation of sodium homeostasis through the maintenance of
external balance regardless of the number of nephrons or of the
dispersion of single-nephron sodium excretion rates.
The magnification phenomenon. The question must be asked
whether, in the progression from 2 million to 30,000 nephrons,
the identical volume pertubation produces a progressively
greater degree of activation of the detector element, thereby
explaining the magnification phenomenon. Although this possi-
bility cannot be ruled out, it seems to me extremely unlikely
that each time a nephron is lost, a change will occur in the
sensitivity of the detector element; for it should be noted that
the magnification phenomenon is characteristic not only of
sodium, but also of phosphate, magnesium, potassium, and
probably a number of other solutes. The detector element for
phosphate probably monitors a change in ionized calcium; that
for potassium may monitor a change in transmembrane chemi-
cal or electrochemical potential gradient; and that for magne-
sium perhaps monitors a change in the concentration of ionized
magnesium, and so forth. If the magnification phenomenon for
even these few solutes were based on a stepwise and simulta-
neous increase in sensitivity of each element, one would have to
invoke multiple separate mechanisms (one for each system)
whereby each wave of nephron loss would "reset" the sensitiv-
ity of each detector mechanism.
The evidence for an increase in production of natriuretic
factor in chronic renal disease already has been cited. What
mediates this increase is unknown, but there is no consistent or
compelling evidence to suggest that the change is due to a
continuous expansion of extracellular fluid volume throughout
the course of chronic renal disease. There are no data, howev-
er, concerning the rate of release of natriuretic factor in
response to the addition of a given amount of sodium at each
level of GFR throughout the entire course of chronic renal
disease. Although such data will be quite difficult to obtain until
a highly sensitive assay system is developed, they ultimately
will be essential to have if the missing pieces of this puzzle are
to be filled in. The possibility that the release rate of the
transmitter element varies as an inverse function of GFR in
response to the ingestion of a fixed amount of sodium thus
cannot be dismissed until the requisite data are obtained.
Another possible explanation for the magnification phenome-
non is that there is an increase in end-organ sensitivity to the
transmitter element and that this heightened response might be
due either to an enhanced intrinsic sensitivity or responsivity of
the nephron and/or to an increase in the number of receptors
per unit of SNGFR or of tubular length. Indirect evidence
supporting increased end-organ sensitivity was obtained in
experiments in which a fixed amount of natriuretic factor was
injected into the renal artery of normal and uremic rats. The
estimated rate of sodium excretion per nephron increased
substantially more in the uremic than in the normal animals
[41].
In summary, the magnification phenomenon is essential for
the preservation of sodium homeostasis in chronic renal disease
and thus for the preservation of life in the presence of progres-
sive nephron loss. Evidence suggests that the activity of the
transmitter element, which inhibits sodium reabsorption by the
distal tubule, may increase in response to a given load of
sodium as GFR falls. Further, end-organ sensitivity might
increase as chronic renal disease advances. This remarkable
magnification phenomenon, the central element of the adapta-
tion in sodium excretion in chronic renal disease, remains
basically unexplained, although many aspects of the phenome-
non should be readily amenable to experimental examination
with modern techniques.
Conclusions
We have examined the processes involved in the mainte-
nance of homeostasis of a single solute, sodium, in healthy
individuals and in patients with chronic renal disease such as
the one presented today. But homeostasis also is maintained
with close precision for a host of other solutes, and for some of
these, the homeostatic process adapts continuously as disease
destroys greater than 90% of the original nephron population. If
a biologic control system does oversee sodium homeostasis, we
believe that biologic control systems probably exist for other
solutes as well. At least some of these control systems, and
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perhaps all, could contain transmitter elements that modulate
tubular transport of their specific solute. Some systems, such as
the one for sodium, however, would require a transmitter that
inhibits reabsorption; others would need a transmitter that
stimulates secretion; and it is conceivable that still others might
require a transmitter element that alters the balance between
reabsorption and secretion. All the systems must be capable of
overriding any interference produced by the action of other
control systems. In general, the rates of acquisition of key
solutes of body fluids vary both randomly and independently of
one another in advancing renal disease as well as in the healthy
state. It is obvious that an increase in sodium intake cannot lead
to a persistent increase in phosphate or potassium excretion
despite the fact that natriuretic factor has been shown to be
phosphaturic and that natriuresis ordinarily increases potassi-
um excretion; moreover, a decrease in sodium intake cannot
lead to a reduction in phosphate excretion, potassium excre-
tion, or the excretion of any other solute that is influenced by
the reabsorption of sodium by tubular epithelial cells.
The unraveling of the nature of solute-specific biologic sys-
tems and the changes that take place in those systems in chronic
renal disease, I believe, represents one of the most interesting
and important biomedical challenges facing us in the coming
decade. Indeed, I would submit that this area stands among the
key unsolved mysteries of mammalian biology.
Questions and answers
DR. BARTON LEVINE (Assistant Professor of Medicine,
Wadsworth VA Medical Center, UCLA School of Medicine,
Los Angeles, California): In what tubular segment or segments
is natriuretic hormone thought to have an effect?
DR. BRICKER: There are recollection micropuncture data that
suggest a modest effect on the proximal tubule [42], but it would
appear that the principal effect is on the cortical collecting
tubule [35].
DR. LEON G. FINE (Director, Nephrology Division, Center
for the Health Sciences, UCLA School of Medicine, Los
Angeles): The data you showed regarding the effects of water
immersion are interesting. However, before one can conclude
that these observations reflect a change in the sensitivity of the
end organ, one must know that the movement of fluid is the
same with the patient on a low or high salt intake. You indicated
that the measured blood volume was the same whether the
patient was on a high- or low-salt diet. I would predict that if
any part of the extracellular fluid composite was protected, it
would be the blood volume. There is a good chance, however,
that the total extracellular fluid volume or the interstitial
volume would be significantly lower when the patient ingested a
low-salt diet, and the differences you report could be explained
by differences in the amount of fluid shifted. Unfortunately, in
water immersion, neither the hematocrit nor a change in protein
concentration can be used to reflect a change in extracellular
volume.
DR. BRICKER: First, I did not intend to imply that the site of
the increased responsivity in the adapted state is necessarily
limited to the nephron. It could reside at any level, or multiple
levels, of the control system. With respect to whether "de-
adaptation" was associated with extracellular fluid volume
contraction, I agree that the equality of plasma volumes in the
adapted and de-adapted states is not in itself sufficiently strong
evidence to rule out this possibility and that some index of
central blood volume, cardiac index, or plethysmographic mea-
surements of the legs would be helpful. Extracorporeal volume
expansion in the adapted versus the unadapted state also would
help to clarify this question, and such studies are being conduct-
ed by Dr. Michael Shapiro in our laboratories.
DR. GABRIEL M. DANOVITCH (Director, Clinical Nephrolo-
gy, Center for the Health Sciences, UCLA School of Medicine,
Los Angeles): We recently reported a patient who manifested
spontaneous changes in sodium excretion very similar to those
seen in the two water immersion studies performed in the
patient under discussion [43]. Our patient suffered the unusual
combination of advanced polycystic renal disease and Crohn's
disease. He had an ileostomy, from which he lost an apprecia-
ble amount of sodium-containing fluid daily. His diet contained
150 mEq of sodium per day, but he excreted only 5 or 6 mEq of
sodium in his urine; the rest was lost in the ileal fluid. This
unique set of circumstances had prevailed for approximately 10
years. Thus, as his renal failure advanced, he did not "need" to
develop an adaptive natriuresis per nephron and, in fact, he
remained "unadapted," excreting virtually no sodium in his
urine. When he was subjected to marked extracellular fluid
volume expansion, his urine contained little or no sodium. Thus
he did not exhibit the magnification phenomenon. We interpret-
ed this as an experiment of nature in which "de-adaptation"
occurred spontaneously. We believe the data are consistent
with the results of the water immersion studies, in which a
magnified natriuresis failed to occur in the absence of adapta-
tion. Later in his course, however, after prolonged volume
repletion, his sodium excretion increased.
DR. BRICKER: This fascinating experiment of nature bears
directly on the key question of whether a preexisting adaptation
is necessary for the magnification phenomenon to work for
sodium. In the case of magnesium (Kirschenbaum MA, Lie-
bross B, Bricker NS, unpublished observations) and probably
potassium [44], adaptation does appear to be necessary for
magnification to occur. In the case of phosphate, however, it
does not [451.
DR. FINE: One could conceive of a hormone-mediated natri-
uresis occurring without an increase in hormone concentration.
If the number of nephrons decreased but an excess of hormone
receptors still existed, more hormone-receptor complexes
would be formed on those remaining nephrons, and a corre-
spondingly greater natriuresis per nephron would ensue. But
when you measure natriuretic hormone with existing bioassay
techniques, the hormone concentration in serum is elevated;
the question is why. Could this increase be related to "steady-
state" blood volume? How adequate are the data on measured
blood volume in uremic patients? If the hormone concentration
is elevated simply because uremic patients have higher blood
volumes than do nonuremic patients, then that elevation could
simply reflect a different steady state and it might not play a role
in governing the excretion of sodium.
DR. BRICKER: Your hormone-receptor theory, if validated,
could help explain the magnification phenomenon. One might
examine whether the isolated perfused cortical collecting tubule
from normal versus uremic, and adapted uremic versus un-
adapted uremic, animals exhibits differences in sensitivity to
the same amounts of natriuretic factor in vitro.
The question of whether blood volume or, more importantly,
extracellular fluid volume is consistently elevated in uremia is
beclouded somewhat by methodologic problems. Thus the
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existing methods, particularly those used for measuring extra-
cellular fluid volume, are not sufficiently precise to allow for a
definitive answer. Some years ago, Schultze studied normal
dogs in which he measured inulin space and blood volume. He
then made the dogs uremic, maintained the same salt intake,
and repeated the space measurements; he found no changes
[24]. More recently Dr. Michael Shapiro has found that inulin
spaces are no greater in uremic than in normal rats and no
greater in sodium-adapted than in sodium-unadapted uremic
rats (unpublished observations). However, the conclusions
drawn from these observations must be tentative because the
error in inulin space measurements must be at least 5%.
DR. JOEL D. KOPPLE (Professor of Medicine and Public
Health, Wadsworth VA Medical Center, UCLA School of
Medicine, Los Angeles): A shift of 700 ml of fluid into the upper
half of the body during water immersion represents less than 3%
of total body water. This is well below the accuracy of these
measurements of extracellular space.
I have a question, Dr. Bricker. I find the welter of data
strongly suggestive that there is a humoral factor. But I find
problematic the length of time it takes to de-adapt a uremic
patient from the presumed effects of this hormone. With every
other hormonal system I am aware of, the adaptive response is
measured in terms of minutes or, at the most, hours; yet in this
instance a patient can become profoundly volume depleted,
including having marked reductions in blood volume, and still
have inappropriate sodium excretion. Granted, it may be be-
cause not only is the circulating hormone increased but also
because the receptors are increased. But don't you find it
troublesome that it takes so many weeks to wean a patient from
the natriuretic state?
DR. BRICKER: Yes. But there is at least one analogous
situation, namely, the uremic patient with poorly suppressible
hyperparathyroidism, in whom it may take a year or longer
before the euparathyroid state is restored after successful renal
transplantation. Also the salt-losing state does not seem to
occur in uremic rats or dogs, possibly because the adaptation in
laboratory animals generally evolves over a very much shorter
period of time than in patients.
DR. JORDAN J. COHEN: Have you ever failed in an attempt to
dc-adapt a patient? That is, do some uremic patients have
unremitting salt wastage?
DR. BRICKER: Dr. Rever, would you like to respond to that?
DR. BARBARA L. REVER (Assistant Professor of Medicine,
Center for the Health Sciences, UCLA School of Medicine, Los
Angeles): I have studied 5 patients and have encountered only
one in whom we could not decrease the daily sodium intake
below 15 mEq. Dr. Danovitch has studied 5 patients and was
successful in all [20]. Thus dc-adaptation has been accom-
plished successfully in 9 of 10 patients.
DR. AMNON LICHT (Assistant Professor of Medicine, Center
for the Health Sciences, UCLA School of Medicine, Los
Angeles): When de-adaptation is attempted too quickly, volume
depletion can develop, requiring saline infusion. However, with
a slower rate of sodium "weaning," the same patient can be de-
adapted successfully. This was apparent in today's patient.
DR. KIY0sHI KUROKAWA (Chief, Nephrology Division,
Wadsworth VA Medical Center, UCLA School of Medicine,
Los Angeles): In uncomplicated patients with chronic renal
failure who ingest a stable sodium intake, have you found a
good correlation between measured plasma volume or plasma
renin activity on the one hand, and the level of sodium intake on
the other?
DR. BRIcKER: Renin values decrease during water immersion
in uremic patients. However, I am not aware of a systematic set
of data that would permit a clear answer to your question.
DR. KUROKAWA: If this sensor system is to be operative in
the presence of chronic renal failure, say in a patient with a
GFR of 10 ml/min and a sodium intake of 100 mEq/day, a small
increase in sodium intake, of say 20 mEq/day, must result in an
equivalent increase in sodium excretion, as would occur in
normal individuals. Given that patients with reduced GFRs are
thought to have high levels of natriuretic factor to start with, it
is unclear how these patients can detect relatively small addi-
tional increments in volume and translate these increases into
the appropriate change in sodium excretion. Because these
patients have high levels of natriuretic factor to start with, it is
hard for me to accept that the same small increase would
produce the same increment in sodium excretion as it does in
normal individuals.
DR. BRICKER: In preliminary studies, again by Dr. Michael
Shapiro, natriuretic factor has been found in the urine of
adapted uremic rats. It is highly likely that the animals used for
the bioassay had high endogenous levels of natriuretic factor.
The addition of 20 mEq/day of sodium, barring different rates of
excretion, would produce the same increment in extracellular
fluid volume in the patient as in the normal person; thus the
increase in endogenous natriuretic factor should be equal.
DR. COHEN: What, if any, influence might an altered diurnal
pattern of sodium input and output have on sodium adaptation?
After all, we don't ingest sodium continuously but rather in
boluses with meals throughout the day. It is conceivable that
the response of a normal individual and of a patient with marked
renal insufficiency to the same increment in sodium intake
could be identical when expressed as mEq/24 hours but quite
different when looked at in temporal profile over a typical day.
Are there any data about the relative rates at which a given
sodium increment, provided in bolus form, is excreted by a
normal person versus a patient with chronic renal failure?
DR. BRICKER: There are both animal and human data, but
there are contradictions. In one study, uremic dogs who re-
ceived a 2.5 g sodium chloride load excreted approximately the
same amount of sodium in 5 hours as did the same dogs before
they became uremic [24]. More recent studies from St. Louis
showed a slower short-term rate of excretion in uremic dogs
[46]. Finally, in studies currently being performed, Danovitch
and Licht have found a consistent increase in excretion of
natriuretic factor in normal individuals between midnight and
4:00 A.M.
DR. MICHAEL A. KIRSCHENBAUM (Assistant Professor of
Medicine, Center for the Health Sciences, UCLA School of
Medicine, Los Angeles): The elusiveness of the identification of
the components of the volume regulation system is very dis-
turbing. In many other biologic control systems, it has been a
great deal easier to identify components. Yet in primate as well
as subprimate studies seeking the elements of the detector limb,
negative results have been obtained; these failures suggest that
perhaps the detector, controller, and effector are located intra-
renally. Maybe we are looking at a purely intrarenal event
which, as Dr. Fine suggests, might overshoot substantially and
which in most situations might not be very selective or
sensitive.
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DR. BRECKER: I can only reiterate the fact that the lower the
GFR, the greater the change in tubular epithelial transport (at
any given value for SNGFR) for a given change in intake of a
single solute, and that the rates and direction of change for
sodium, as well as for other substances, are solute specific and
geared to the preservation of homeostasis. Also, the ability to
"wean" a chronically uremic patient of dietary sodium with no
consistent change in plasma sodium concentration, plasma
volume, or GFR bespeaks a highly ordered control system.
DR. KUROKAWA: Dr. Fine has demonstrated that natriuretic
factor modulates sodium transport in the cortical collecting
tubule. It should be feasible, therefore, for one to compare the
response of tubules obtained from animals with chronic renal
failure with th&se obtained from normal controls. If one pro-
duces a dose-response curve using the same source of natriuret-
Ic factor in serial dilutions, shouldn't one be able to demon-
strate differences in the sensitivity—that is, a shift of the
response curve to the right or left—as well as differences in the
responsiveness—that is, the magnitude—of tubular response?
DR. BRICKER: We are in the process of studying the natriuret-
Ic effect of urine fractions from adapted versus de-adapted rats
using adapted and de-adapted rats for bioassay. The studies you
suggest are important and I hope they will be done soon.
But let me make one other point with regard to your question.
One can make dogs uremic by reducing nephron mass in serial
steps; if salt in the diet is decreased in exact proportion to the
decrease in GFR, such animals will become uremic and have no
increase in natriuresis per nephron; moreover, the bioassay for
natriuretic hormone will remain negative [34]. Your question
could be answered by studying isolated perfused cortical col-
lecting tubules from such nephrons and comparing the results to
those obtained in nephrons from uremic animals with high
levels of natriuretic factor.
DR. HECTOR J. RODRIGUEZ (Assistant Clinical Professor of
Medicine, UCLA School of Medicine, Los Angeles): You have
included aldosterone in your scheme as a modulator of sodium
excretion. Does available evidence permit one to exclude
changes in sensitivity or responsiveness of the surviving neph-
rons to aldosterone levels?
DR. BRICKER: I think aldosterone plays a very important role
in sodium homeostasis. But experimental observations suggest
that if one maintains mineralocorticoid hormone levels in a
uremic dog or patient at a fixed level, whether this be very low
or very high, and if one modifies the sodium intake, sodium
balance will be maintained [16, 24].
DR. FINE: Gruber, Whitaker, and Buckalew recently report-
ed a circulating ouabain-like substance [40]. Do you think they
have discovered the natriuretic hormone?
DR. BRICKER: Although samples have not been exchanged
between laboratories—and in my view, there is an urgent need
that this be done—they believe that their inhibitor can be
measured using a radioimmunoassay for digoxin. I don't know
whether their substance is natriuretic hormone, but, as I noted
earlier, natriuretic hormone could be an endogenous, digitalis
glycoside-like compound. Many characteristics of the hormone
resemble those of ouabain: the hormone is active only when
added to the basolateral or blood surface, it increases intracellu-
lar sodium content, it blocks sodium efflux but doesn't affect
sodium influx, it decreases oxidative phosphorylation, it has the
right molecular weight, and there are other similarities.
DR. FINE: Let's say then that Gruber, Whitaker, and Bucka-
lew do have a circulating natriuretic substance. Does one stop
there and say the natriuretic hormone has been discovered, or
does one go on looking for another natriuretic hormone?
DR. BRICKER: I'd be happy with one!
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